Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lina Jansen

Showing results (81-90 of 190) with videos related to

Pageof 19
Sort By:
Acta Oncologica (Stockholm, Sweden)|April 25, 2012
Survival of stomach and esophagus cancer patients in Germany in the early 21st centuryEva Hiripi, Lina Jansen, Adam Gondos, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2017
Survival for patients with rare haematologic malignancies: Changes in the early 21st centuryDianne Pulte, Janick Weberpals, Lina Jansen, et al.
Plos One|July 18, 2013
Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in GermanyOndrej Majek, Adam Gondos, Lina Jansen, et al.
Plos One|January 26, 2013
Survival of patients with oral cavity cancer in GermanyStefan Listl, Lina Jansen, Albrecht Stenzinger, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 15, 2012
Survival of ovarian cancer patients in Germany in the early 21st century: a period analysis by age, histology, laterality, and stageTianhui Chen, Lina Jansen, Adam Gondos, et al.
Journal of the National Cancer Institute|March 15, 2015
Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustmentMichael Hoffmeister, Lina Jansen, Anja Rudolph, et al.
Clinical Epidemiology|September 15, 2018
Comparative performance of a modified landmark approach when no time of treatment data are available within oncological databases: exemplary cohort study among resected pancreatic cancer patientsJanick Weberpals, Lina Jansen, Geert Silversmit, et al.
International Journal of Cancer|September 16, 2016
Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancerMelanie Maierthaler, Axel Benner, Michael Hoffmeister, et al.
BMC Cancer|November 8, 2014
Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control studyAnja Rudolph, Hong Shi, Asta Försti, et al.
International Journal of Cancer|April 15, 2014
Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patientsSusanne Dihlmann, Sha Tao, Fabian Echterdiek, et al.
Pageof 19

Showing results (81-90 of 190) with videos related to

Sort By:
Pageof 19
Acta Oncologica (Stockholm, Sweden)|April 25, 2012
Survival of stomach and esophagus cancer patients in Germany in the early 21st centuryEva Hiripi, Lina Jansen, Adam Gondos, et al.
European Journal of Cancer (Oxford, England : 1990)|August 12, 2017
Survival for patients with rare haematologic malignancies: Changes in the early 21st centuryDianne Pulte, Janick Weberpals, Lina Jansen, et al.
Plos One|July 18, 2013
Sex differences in colorectal cancer survival: population-based analysis of 164,996 colorectal cancer patients in GermanyOndrej Majek, Adam Gondos, Lina Jansen, et al.
Plos One|January 26, 2013
Survival of patients with oral cavity cancer in GermanyStefan Listl, Lina Jansen, Albrecht Stenzinger, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|June 15, 2012
Survival of ovarian cancer patients in Germany in the early 21st century: a period analysis by age, histology, laterality, and stageTianhui Chen, Lina Jansen, Adam Gondos, et al.
Journal of the National Cancer Institute|March 15, 2015
Statin use and survival after colorectal cancer: the importance of comprehensive confounder adjustmentMichael Hoffmeister, Lina Jansen, Anja Rudolph, et al.
Clinical Epidemiology|September 15, 2018
Comparative performance of a modified landmark approach when no time of treatment data are available within oncological databases: exemplary cohort study among resected pancreatic cancer patientsJanick Weberpals, Lina Jansen, Geert Silversmit, et al.
International Journal of Cancer|September 16, 2016
Plasma miR-122 and miR-200 family are prognostic markers in colorectal cancerMelanie Maierthaler, Axel Benner, Michael Hoffmeister, et al.
BMC Cancer|November 8, 2014
Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control studyAnja Rudolph, Hong Shi, Asta Försti, et al.
International Journal of Cancer|April 15, 2014
Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patientsSusanne Dihlmann, Sha Tao, Fabian Echterdiek, et al.
Pageof 19